BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//University of Manitoba//UMFOD Calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:6a11fc401241e@umanitoba.ca
SUMMARY:Preventive Immunotherapeutics in IBD - Internal Deadline
DESCRIPTION:Preventive Immunotherapeutics in IBD\n\nThe postoperative period represents a unique biological window before immune tolerance is lost and inflammation becomes re-established. Through this academic-focused initiative, the Foundation seeks to advance translational, multi-year research on immune memory, antigen-specific responses, and immune regulation to inform next-generation prophylactic immunotherapeutic strategies.\n\nAwards will provide up to $900,000 over three years ($300,000 per year), contingent upon achievement of annual milestones.\n\n\nInternal Application Deadline: Sep 10, 2026 \n\nUMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4282\n\nProgram URL: https://www.crohnscolitisfoundation.org/research/grants-fellowships/immunotherapeutics-rfp\nInternal Deadline
X-ALT-DESC;FMTTYPE=text/html:<html><body>Preventive Immunotherapeutics in IBD<br /><br />The postoperative period represents a unique biological window before immune tolerance is lost and inflammation becomes re-established. Through this academic-focused initiative\, the Foundation seeks to advance translational\, multi-year research on immune memory\, antigen-specific responses\, and immune regulation to inform next-generation prophylactic immunotherapeutic strategies.<br /><br />Awards will provide up to $900\,000 over three years ($300\,000 per year)\, contingent upon achievement of annual milestones.<br /><br /><br />Internal Application Deadline: Sep 10\, 2026 <br /><br />UMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4282<br /><br />Program URL: https://www.crohnscolitisfoundation.org/research/grants-fellowships/immunotherapeutics-rfp</body></html>
DTSTART:20260910T083000
DTEND:20260910T093000
BEGIN:VALARM
TRIGGER:-P2D
ACTION:DISPLAY
DESCRIPTION:Reminder for Preventive Immunotherapeutics in IBD
END:VALARM
END:VEVENT
END:VCALENDAR
